Changes related to "Cisplatin (Platinol)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 10:16, 14 December 2018
   
Page name:

13 December 2018

 m   22:18  Breast cancer‎ (diff | hist) . . (+7,116). . Jwarner (talk | contribs)
 m   21:53  Non-small cell lung cancer‎ (diff | hist) . . (+1,468). . Jwarner (talk | contribs)

12 December 2018

 m   21:38  Testicular cancer‎ (diff | hist) . . (+2,037). . Jwarner (talk | contribs)
 m   11:56  Cholangiocarcinoma‎ (diff | hist) . . (+1,305). . Jwarner (talk | contribs) (All lines of therapy)
 m   11:52  Gastric cancer‎ (diff | hist) . . (+808). . Jwarner (talk | contribs) (CX {{#subobject:2bd34d|Regimen=1}})
     11:26  Head and neck cancer‎‎ (2 changes | history) . . (+3,110). . [Jwarner‎ (2×)]
      11:26 (cur | prev) . . (+2,074). . Jwarner (talk | contribs) (Carboplatin, Fluorouracil, RT {{#subobject:c1e2f9|Regimen=1}})
 m    11:16 (cur | prev) . . (+1,036). . Jwarner (talk | contribs) (Carboplatin, Fluorouracil, RT {{#subobject:c1e2f9|Regimen=1}})
     09:05  Small cell lung cancer‎‎ (3 changes | history) . . (+4,022). . [Jwarner‎ (3×)]
 m    09:05 (cur | prev) . . (+8). . Jwarner (talk | contribs) (Carboplatin, Etoposide, Atezolizumab {{#subobject:760b97|Regimen=1}})
 m    09:04 (cur | prev) . . (+1,503). . Jwarner (talk | contribs) (Bevacizumab monotherapy {{#subobject:e2a180|Regimen=1}})
      09:02 (cur | prev) . . (+2,511). . Jwarner (talk | contribs) (Carboplatin & Etoposide {{#subobject:de3ba6|Regimen=1}})

11 December 2018

 m   18:33  SCC of unknown primary‎ (diff | hist) . . (+89). . Jwarner (talk | contribs) (All lines of therapy)
 m   18:32  Head and neck cancer‎ (diff | hist) . . (+74). . Jwarner (talk | contribs) (Subsequent treatment)

10 December 2018

 m   22:09  Hepatoblastoma‎‎ (2 changes | history) . . (+813). . [Jwarner‎ (2×)]
 m    22:09 (cur | prev) . . (+68). . Jwarner (talk | contribs) (Cisplatin & Doxorubicin {{#subobject:7bb59c|Regimen=1}})
 m    22:08 (cur | prev) . . (+745). . Jwarner (talk | contribs) (Cisplatin & Doxorubicin {{#subobject:7bb59c|Regimen=1}})
 m   22:04  Head and neck cancer‎ (diff | hist) . . (+6,256). . Jwarner (talk | contribs)
 m   15:42  Melanoma‎ (diff | hist) . . (0). . Jwarner (talk | contribs) (References)
 m   15:41  Non-small cell lung cancer‎ (diff | hist) . . (-3). . Jwarner (talk | contribs)
 m   15:26  Hodgkin lymphoma‎‎ (2 changes | history) . . (+1,691). . [Jwarner‎ (2×)]
 m    15:26 (cur | prev) . . (+1,112). . Jwarner (talk | contribs) (Flu-Mel, then allo HSCT {{#subobject:6f8499|Regimen=1}})
 m    13:06 (cur | prev) . . (+579). . Jwarner (talk | contribs) (MOPP {{#subobject:bcde0|Regimen=1}})
 m   12:52  Gastric cancer‎ (diff | hist) . . (+13). . Jwarner (talk | contribs)
 m   12:50  Esophageal cancer‎ (diff | hist) . . (+1,289). . Jwarner (talk | contribs)

9 December 2018

 m   17:36  Mantle cell lymphoma‎ (diff | hist) . . (+1,134). . Jwarner (talk | contribs) (Observation)
 m   16:52  Cervical cancer‎‎ (2 changes | history) . . (+4,442). . [Jwarner‎ (2×)]
 m    16:52 (cur | prev) . . (0). . Jwarner (talk | contribs) (Regimen {{#subobject:a3542f|Variant=1}})
 m    16:51 (cur | prev) . . (+4,442). . Jwarner (talk | contribs)
 m   13:48  Cholangiocarcinoma‎ (diff | hist) . . (+80). . Jwarner (talk | contribs) (Fluorouracil & Folinic acid {{#subobject:7bfb92|Regimen=1}})
 m   10:49  Adenocarcinoma of unknown primary‎ (diff | hist) . . (+134). . Jwarner (talk | contribs) (Cisplatin monotherapy {{#subobject:21015c|Regimen=1}})
 m   10:46  Non-small cell lung cancer‎ (diff | hist) . . (+4,277). . Jwarner (talk | contribs)

8 December 2018

 m   20:32  Pancreatic cancer‎ (diff | hist) . . (+2,449). . Jwarner (talk | contribs)
 m   20:04  Ovarian cancer‎ (diff | hist) . . (+3,960). . Jwarner (talk | contribs) (Paclitaxel monotherapy {{#subobject:57d35e|Regimen=1}})
 m   19:02  Nasopharyngeal carcinoma‎ (diff | hist) . . (+1,030). . Jwarner (talk | contribs) (Cisplatin & Fluorouracil {{#subobject:b42ea5|Regimen=1}})
 m   14:52  Non-small cell lung cancer‎‎ (2 changes | history) . . (+877). . [Jwarner‎ (2×)]
 m    14:52 (cur | prev) . . (+193). . Jwarner (talk | contribs) (Atezolizumab & Bevacizumab {{#subobject:ef3aef|Regimen=1}})
 m    14:51 (cur | prev) . . (+684). . Jwarner (talk | contribs) (ABCP {{#subobject:ee72af|Regimen=1}})

7 December 2018

 m   21:15  Mesothelioma‎ (diff | hist) . . (+1,910). . Jwarner (talk | contribs)
 m   20:01  Melanoma‎ (diff | hist) . . (+8,090). . Jwarner (talk | contribs)
 m   14:34  Gastric cancer‎ (diff | hist) . . (+2,712). . Jwarner (talk | contribs)
 m   13:01  Endometrial cancer‎‎ (4 changes | history) . . (+2,014). . [Jwarner‎ (4×)]
 m    13:01 (cur | prev) . . (+714). . Jwarner (talk | contribs) (Endocrine therapy for advanced, recurrent, or metastatic disease)
 m    12:13 (cur | prev) . . (+706). . Jwarner (talk | contribs) (Medroxyprogesterone acetate monotherapy {{#subobject:6c7bb9|Regimen=1}})
 m    10:03 (cur | prev) . . (+594). . Jwarner (talk | contribs) (Doxorubicin monotherapy {{#subobject:e5b103|Regimen=1}})
 m    09:55 (cur | prev) . . (0). . Jwarner (talk | contribs) (Whole abdominal radiation (WAI) {{#subobject:37c051|Regimen=1}})
 m   09:49  Diffuse large B-cell lymphoma‎‎ (9 changes | history) . . (+2,856). . [Jwarner‎ (9×)]
 m    09:49 (cur | prev) . . (+279). . Jwarner (talk | contribs)
 m    09:48 (cur | prev) . . (+134). . Jwarner (talk | contribs) (Vinorelbine monotherapy {{#subobject:29c647|Regimen=1}})
 m    09:47 (cur | prev) . . (+676). . Jwarner (talk | contribs) (Rituximab monotherapy {{#subobject:d826ec|Regimen=1}})
 m    09:44 (cur | prev) . . (+124). . Jwarner (talk | contribs) (Variant #1, 100 mg/m2 {{#subobject:1fc8c3|Variant=1}})
 m    09:43 (cur | prev) . . (+124). . Jwarner (talk | contribs) (Ifosfamide monotherapy {{#subobject:b9a669|Regimen=1}})
 m    09:41 (cur | prev) . . (+134). . Jwarner (talk | contribs) (Variant #3, indefinite 3 out of 4 weeks {{#subobject:4d3a21|Variant=1}})
 m    09:40 (cur | prev) . . (+642). . Jwarner (talk | contribs) (Etoposide monotherapy {{#subobject:1ed00b|Regimen=1}})
 m    09:13 (cur | prev) . . (+135). . Jwarner (talk | contribs) (Variant #1, 750/300/800/800/140 {{#subobject:9131e1|Variant=1}})
 m    09:08 (cur | prev) . . (+608). . Jwarner (talk | contribs) (R-CHOEP-14 {{#subobject:75c24e|Regimen=1}})

6 December 2018

 m   23:19  Hodgkin lymphoma‎‎ (2 changes | history) . . (+1,366). . [Jwarner‎ (2×)]
 m    23:19 (cur | prev) . . (+673). . Jwarner (talk | contribs) (ChlVPP/EVA {{#subobject:8ee324|Regimen=1}})
 m    23:11 (cur | prev) . . (+693). . Jwarner (talk | contribs) (Observation)